H. Wieand

发表

A comparison of laparoscopically assisted and open colectomy for colon cancer.

J. Fleshman, D. Sargent, H. Nelson, 2004, The New England journal of medicine.

Prospective evaluation of prognostic variables from patient-completed questionnaires. North Central Cancer Treatment Group.

P. Novotny, H. Wieand, C. Loprinzi, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adjuvant treatment of rectal cancer: Randomized prospective study of irradiation ± chemotherapy — A NCCTG, Mayo clinic study

J. Earle, H. Wieand, R. Beart, 1986 .

Is relative risk reduction a useful measure for patients or families who must choose a method of treatment?

H. Wieand, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comparison of estrogen receptor determinations by a biochemical ligand‐binding assay and immunohistochemical staining with monoclonal antibody ER1D5 in females with lymph node positive breast carcinoma entered on two prospective clinical trials

H. Wieand, J. Ingle, J. Krook, 1996, Cancer.

DNA ploidy and cell kinetic measurements as predictors of recurrence and survival in stages B2 and C colorectal adenocarcinoma

H. Wieand, C. Loprinzi, J. Katzmann, 1991, Cancer.

External beam and intraoperative electron irradiation for locally advanced soft tissue sarcomas.

F. Sim, A. Martinez, H. Wieand, 1993, International journal of radiation oncology, biology, physics.

Prognostic factors in elderly women with metastatic breast cancer treated with tamoxifen: An analysis of patients entered on four prospective clinical trials

M. Dhodapkar, H. Wieand, J. Ingle, 1996, Cancer.

Intraoperative radiotherapy for unresectable cholangiocarcinoma--the Mayo Clinic experience.

H. Wieand, D. Nagorney, C. Bender, 1992, Surgical oncology.

Intraoperative and external beam irradiation +/- 5-FU for locally advanced pancreatic cancer.

J. K. Martin, J. Earle, A. Martinez, 1987, International journal of radiation oncology, biology, physics.

Intraoperative and External Beam Irradiation for Locally Advanced Colorectal Cancer

J. K. Martin, A. Martinez, H. Wieand, 1988, Annals of surgery.

Combined doxorubicin and alpha‐interferon therapy of advanced hepatocellular carcinoma

H. Wieand, J. Krook, M. O’connell, 1993, Cancer.

Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery.

H. Wieand, J. Krook, M. O’connell, 1994, The New England journal of medicine.

A prospective, randomized evaluation of intensive‐course 5‐fluorouracil plus doxorubicin as surgical adjuvant chemotherapy for resected gastric cancer

H. Wieand, R. Beart, J. Krook, 1991, Cancer.

Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials.

Daniel J Sargent, Daniel G Haller, Marc Buyse, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Analysis of Cause-Specific Events in Competing Risks Survival Data

John Bryant, James J. Dignam, H.Sam Wieand, 2003, Advances in Survival Analysis.

Wound recurrence following conventional treatment of colorectal cancer

H. Nelson, H. Wieand, M. O’connell, 1996, Diseases of the colon and rectum.

32 Application of nonparametric statistics to cancer data

H. S. Wieand, H. Wieand, 1984, Nonparametric Methods.

A clinical trial to evaluate the worth of preoperative multimodality therapy in patients with operable carcinoma of the rectum

H. Rockette, N. Petrelli, H. Wieand, 1997, Diseases of the colon and rectum.

Proposed phase III trial comparing laparoscopic-assisted colectomy versus open colectomy for colon cancer.

H. Nelson, H. Wieand, J. Weeks, 1995, Journal of the National Cancer Institute. Monographs.

A phase ii study of the combination of etoposide and cisplatin in the therapy of advanced gastric cancer

H. Wieand, R. Hahn, H. Wieand, 1990, Cancer.

Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer.

H. Wieand, M. O’connell, D. Haller, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. A randomized trial.

J. K. Martin, R. Fitzgibbons, H. Wieand, 1990, Archives of surgery.

Biochemical modulation of fluorouracil with leucovorin: confirmatory evidence of improved therapeutic efficacy in advanced colorectal cancer.

H. Wieand, J. Krook, M. O’connell, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer.

M. Kahn, R. Fitzgibbons, J. Donohue, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Improved therapeutic ratio with protracted venous infusion (PVI) 5-fluorouracil (5FU) during postoperative external beam radiotherapy for high-risk rectal cancer

H. Wieand, J. Krook, M. O’connell, 1993 .

Effective surgical adjuvant therapy for high-risk rectal carcinoma.

W. Meyers, S. Cha, H. Wieand, 1991, The New England journal of medicine.

Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic.

T. Fleming, H. Wieand, J. Laurie, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Validation studies for models projecting the risk of invasive and total breast cancer incidence.

J Benichou, M H Gail, C K Redmond, 1999, Journal of the National Cancer Institute.

Controlled evaluation of three drug combination regimens versus fluorouracil alone for the therapy of advanced gastric cancer. North Central Cancer Treatment Group.

H. Wieand, J. Krook, M. O’connell, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The prognostic significance of tumor location and bowel obstruction in Dukes B and C colorectal cancer. Findings from the NSABP clinical trials.

H. Rockette, H. Wieand, N. Wolmark, 1983, Annals of surgery.

Colorectal cancer. Dukes' stage, tumor site, preoperative plasma CEA level, and patient prognosis related to tumor DNA ploidy pattern.

S. Cha, H. Wieand, R. Beart, 1987, Archives of surgery.

Stage I ovarian epithelial carcinoma: survival analysis following definitive treatment.

S. Cha, H. Wieand, K. Podratz, 1991, Gynecologic oncology.

Accuracy of fecal occult blood screening for colorectal neoplasia. A prospective study using Hemoccult and HemoQuant tests.

H. Wieand, D. Ahlquist, C. Loprinzi, 1993, JAMA.

Randomized comparison of two schedules of fluorouracil and leucovorin in the treatment of advanced colorectal cancer.

H. Wieand, J. Krook, M. O’connell, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Evaluation of treatment and survival after positive second-look laparotomy.

H. Wieand, G. Malkasian, J. A. Jefferies, 1988 .

Expression of anionic glutathione-S-transferase and P-glycoprotein genes in human tissues and tumors.

H. Wieand, K. Cowan, C. Fairchild, 1989, Cancer research.

Granulocyte colony-stimulating factor in severe chemotherapy-induced afebrile neutropenia.

T. Habermann, L. Hartmann, H. Wieand, 1997, The New England journal of medicine.

Perioperative blood transfusions do not affect disease recurrence of patients undergoing curative resection of colorectal carcinoma: a Mayo/North Central Cancer Treatment Group study.

R. Fitzgibbons, S. Cha, J. Donohue, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A quality-adjusted time without symptoms or toxicity (Q-TWiST) analysis of adjuvant radiation therapy and chemotherapy for resectable rectal cancer.

R. Gelber, H. Wieand, A. Goldhirsch, 1996, Journal of the National Cancer Institute.

Investigation of disease-free survival as a surrogate endpoint for survival in cancer clinical trials

H. Wieand, A. Lindblad, B. Fisher, 1998 .